Evidence map›Paper›PMID 34502201›Full record

ArticleInternational journal of molecular sciences2021

Dissecting Breast Cancer Circulating Tumor Cells Competence via Modelling Metastasis in Zebrafish.

Inés Martínez-Pena, Pablo Hurtado, Nuria Carmona-Ule, Carmen Abuín, Ana Belén Dávila-Ibáñez, Laura Sánchez, Miguel Abal, Anas Chaachou, Javier Hernández-Losa, Santiago Ramón Y Cajal and 2 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Advancements in Zebrafish Models for Breast Cancer Research: Unveiling Biomarkers, Targeted Therapies, and Personalized Medicine.Medical science monitor : international medical journal of experimental and clinical research · 2023
    Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Zebrafish-An Optimal Model in Experimental Oncology.Molecules (Basel, Switzerland) · 2022
    Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Inés Martínez-PenaRoche-Chus Joint Unit, Translational Medical Oncology Group, Oncomet, Health Research Institute of Santiago de Compostela, Travesía da Choupana s/n, 15706 Santiago de Compostela, Spain.ORCID 0000-0001-5595-3405
Pablo HurtadoRoche-Chus Joint Unit, Translational Medical Oncology Group, Oncomet, Health Research Institute of Santiago de Compostela, Travesía da Choupana s/n, 15706 Santiago de Compostela, Spain.
Nuria Carmona-UleRoche-Chus Joint Unit, Translational Medical Oncology Group, Oncomet, Health Research Institute of Santiago de Compostela, Travesía da Choupana s/n, 15706 Santiago de Compostela, Spain.ORCID 0000-0001-6312-6530
Carmen AbuínRoche-Chus Joint Unit, Translational Medical Oncology Group, Oncomet, Health Research Institute of Santiago de Compostela, Travesía da Choupana s/n, 15706 Santiago de Compostela, Spain.ORCID 0000-0002-6902-4161
Ana Belén Dávila-IbáñezRoche-Chus Joint Unit, Translational Medical Oncology Group, Oncomet, Health Research Institute of Santiago de Compostela, Travesía da Choupana s/n, 15706 Santiago de Compostela, Spain.ORCID 0000-0002-9906-5458
Laura SánchezDepartamento de Zoología, Genética y Antropología Física, Facultad de Veterinaria, Universidade de Santiago de Compostela, 27002 Lugo, Spain.ORCID 0000-0001-7927-5303
Miguel AbalCIBERONC, Centro de Investigación Biomédica en Red Cáncer, 28029 Madrid, Spain.ORCID 0000-0003-3533-7781
Anas ChaachouTranslational Molecular Pathology, Department of Pathology, Vall d'Hebron Institute of Research (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.
Javier Hernández-LosaCIBERONC, Centro de Investigación Biomédica en Red Cáncer, 28029 Madrid, Spain.ORCID 0000-0003-1526-3201
Santiago Ramón Y CajalCIBERONC, Centro de Investigación Biomédica en Red Cáncer, 28029 Madrid, Spain.ORCID 0000-0002-3867-1390
Rafael López-LópezRoche-Chus Joint Unit, Translational Medical Oncology Group, Oncomet, Health Research Institute of Santiago de Compostela, Travesía da Choupana s/n, 15706 Santiago de Compostela, Spain.
Roberto PiñeiroRoche-Chus Joint Unit, Translational Medical Oncology Group, Oncomet, Health Research Institute of Santiago de Compostela, Travesía da Choupana s/n, 15706 Santiago de Compostela, Spain.ORCID 0000-0001-9479-139X
Universitat Autònoma de Barcelona · ESCentro de Investigación Biomédica en Red de Cáncer · ESComplejo Hospitalario Universitario de Santiago · ESInstituto de Investigación Sanitaria de Santiago · ESUniversidade de Santiago de Compostela · ES

Funding

Axencia Galega de Innovación IN853B 2018/03
6 · The paper itself

Abstract

backgroundCancer metastasis is a deathly process, and a better understanding of the different steps is needed. The shedding of circulating tumor cells (CTCs) and CTC-cluster from the primary tumor, its survival in circulation, and homing are key events of the metastasis cascade. In vitro models of CTCs and in vivo models of metastasis represent an excellent opportunity to delve into the behavior of metastatic cells, to gain understanding on how secondary tumors appear.

methodsUsing the zebrafish embryo, in combination with the mouse and in vitro assays, as an in vivo model of the spatiotemporal development of metastases, we study the metastatic competency of breast cancer CTCs and CTC-clusters and the molecular mechanisms.

resultsCTC-clusters disseminated at a lower frequency than single CTCs in the zebrafish and showed a reduced capacity to invade. A temporal follow-up of the behavior of disseminated CTCs showed a higher survival and proliferation capacity of CTC-clusters, supported by their increased resistance to fluid shear stress. These data were corroborated in mouse studies. In addition, a differential gene signature was observed, with CTC-clusters upregulating cell cycle and stemness related genes.

conclusionsThe zebrafish embryo is a valuable model system to understand the biology of breast cancer CTCs and CTC-clusters.

Indexed as

Disease Models, AnimalNeoplastic Cells, CirculatingAnimalsBreast NeoplasmsCell Line, TumorEmbryo, NonmammalianFemaleHumansMCF-7 CellsMiceNeoplasm MetastasisZebrafishbreast cancercell survivalcirculating tumor cells (CTCs)CTC-clustersin vitro modelsin vivo modelsmetastasiszebrafish

Identifiers

PMID34502201
PMCPMC8431683
OpenAlexW3197381724

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.